Who is the Top Investor In Arbutus Biopharma Corp (ABUS)?
Arbutus Biopharma Corp (NASDAQ: ABUS) is 27.60% higher on its value in year-to-date trading and has touched a low of $2.21 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Arbutus Biopharma Corp (ABUS) – Don’t Be So Quick to Call it Dead
Arbutus Biopharma Corp (NASDAQ: ABUS) is 45.20% higher on its value in year-to-date trading and has touched a low of $1.98 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Arbutus Biopharma Corp (ABUS) – Don’t Believe the Hype: Check The Facts
Arbutus Biopharma Corp (NASDAQ: ABUS) is 38.80% higher on its value in year-to-date trading and has touched a low of $1.79 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Which institution holds the most shares in Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (NASDAQ: ABUS) is 38.40% higher on its value in year-to-date trading and has touched a low of $1.79 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
A peek at Arbutus Biopharma Corp (ABUS): Who has invested in It?
Arbutus Biopharma Corp (NASDAQ: ABUS) is 49.20% higher on its value in year-to-date trading and has touched a low of $1.70 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Arbutus Biopharma Corp (ABUS) – Don’t Be So Quick to Call it Dead
Arbutus Biopharma Corp (NASDAQ: ABUS) is 62.40% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Here is a breakdown of major shareholders in Arbutus Biopharma Corp (NASDAQ: ABUS)
Arbutus Biopharma Corp (NASDAQ: ABUS) is 64.80% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Who are the Institutional Holders in Arbutus Biopharma Corp (ABUS)?
Arbutus Biopharma Corp (NASDAQ: ABUS) is 51.60% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Here are the top Institutional holders of Arbutus Biopharma Corp (ABUS) shares
Arbutus Biopharma Corp (NASDAQ: ABUS) is 56.00% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
Things appear to be looking up for Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (NASDAQ: ABUS) is 60.80% higher on its value in year-to-date trading and has touched a low of $1.69 and a high of $4.72 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will […]
